Thursday – Basic Science Track A

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2026.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
BoNT exploit host proteases to boost their oral toxicity via activating OrfX/P47
Rongsheng Jin, PhD (USA)
Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70
Paul Stenmark, PhD (Sweden)
M-PTC/HA70 complex structure
Andreas Rummel, PhD (Germany)
The Expanding Family of BoNT-like Toxins: Evolution, Diversity, and Function
Andrew C. Doxey, PhD (Canada)
Identification and Characterization of Botulinum Neurotoxin-like Two-Component Toxins in Paeniclostridium ghonii
Pyung-Gang Lee, PhD (USA)
YesNo
BoNT exploit host proteases to boost their oral toxicity via activating OrfX/P47
Rongsheng Jin, PhD (USA)
Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70
Paul Stenmark, PhD (Sweden)
M-PTC/HA70 complex structure
Andreas Rummel, PhD (Germany)
The Expanding Family of BoNT-like Toxins: Evolution, Diversity, and Function
Andrew C. Doxey, PhD (Canada)
Identification and Characterization of Botulinum Neurotoxin-like Two-Component Toxins in Paeniclostridium ghonii
Pyung-Gang Lee, PhD (USA)
YesNo
BoNT exploit host proteases to boost their oral toxicity via activating OrfX/P47
Rongsheng Jin, PhD (USA)
Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70
Paul Stenmark, PhD (Sweden)
M-PTC/HA70 complex structure
Andreas Rummel, PhD (Germany)
The Expanding Family of BoNT-like Toxins: Evolution, Diversity, and Function
Andrew C. Doxey, PhD (Canada)
Identification and Characterization of Botulinum Neurotoxin-like Two-Component Toxins in Paeniclostridium ghonii
Pyung-Gang Lee, PhD (USA)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Scam Warning

Due to scam emails being sent, please note that INA will NOT email you to wire money to anyone on the Board of Directors or anyone else from the INA.

Join Our Mailing List

Click here to sign up, and then manage your subscription.